Company / Shareholders' Equity
Erasca, Inc. Shareholders' Equity History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$423.5M
FY2024
5-year range
-$114.0M / $456.5M
FY2020-FY2024
Trend
+33.7%
vs FY2023
Sector context
#104 of 213
Health Care
What the data says
At $423M, Erasca, Inc.'s shareholders' equity ranks #104 of 213 in the Health Care sector. Shareholders' Equity returned to growth in FY2024 after 2 years of decline, reaching $423M.
Based on SEC 10-K filings.
$423M in FY2024 with a 3-year CAGR of -2.5%.
Improved from $412M to $423M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -2.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#104 of 213 in Health CareTop 49% of 213This company $423.5M Sector average $2.5B
▼
-83.4% below sector average
Key checks
Key Insights
- 3-year CAGR of -2.5%, indicating a declining trend.
- In FY2024, shareholders' equity increased 33.7% year-over-year.
- Ranks #104 out of 213 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $423.5M | +33.7% |
| FY2023 | $316.7M | -23.1% |
| FY2022 | $411.9M | -9.8% |
| FY2021 | $456.5M | +500.5% |
| FY2020 | -$114.0M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026